INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "TRANSGENE GENOMIC IDENTIFICATION BY NUCLEASE-MEDIATED LONG READ SEQUENCING"

GENEVA, Nov. 18 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/027765) for "TRANSGENE GENOMIC IDENTIFICATION BY NUCLEASE-MEDIATED LONG READ SEQUENCING" on May 05, 2025. With publication no. WO/2025/235388, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TURNER, Terrence (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591), ROJAS, Jose F. (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarry...